These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7479674)

  • 1. Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein.
    Pescador R; Manso MA; Rebollo AJ; de Dios I
    Pancreas; 1995 Aug; 11(2):165-72. PubMed ID: 7479674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis.
    Murayama KM; Drew JB; Nahrwold DL; Joehl RJ
    Pancreas; 1990 Jul; 5(4):439-44. PubMed ID: 1696383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zymogen granule alterations in caerulein-induced pancreatitis developed during continuous hydrocortisone administration.
    García-Montero AC; Manso MA; Orfao A; Vicente S; De Dios I
    Eur J Clin Invest; 1999 Jun; 29(6):496-503. PubMed ID: 10354211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recovery of acute pancreatitis depends on the enzyme amount stored in zymogen granules at early stages.
    Manso MA; García-Montero AC; Tabernero MD; Orfao A; De Dios I
    Mol Cell Biochem; 1999 Oct; 200(1-2):35-41. PubMed ID: 10569181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of CCK on CDE diet-induced acute pancreatitis in rats treated with hydrocortisone.
    Manso MA; Rebollo A; Pescador R; de Dios I
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jun; 111(2):257-63. PubMed ID: 8521247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced acute pancreatitis.
    Garcia-Montero AC; Manso MA; Rodriguez AI; De Dios I
    Pancreas; 1994 May; 9(3):309-15. PubMed ID: 7517544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholecystokinin blockade on the recovery of alterations induced by acute pancreatitis in glycoconjugates of rat zymogen granules.
    De Dios I; Garcia-Montero AC; Orfao A; Manso MA
    Glycoconj J; 1998 Sep; 15(9):923-8. PubMed ID: 10052596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
    Nakano S; Kihara Y; Otsuki M
    Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic fluid hypersecretion in rats after acute pancreatitis.
    Czakó L; Yamamoto M; Otsuki M
    Dig Dis Sci; 1997 Feb; 42(2):265-72. PubMed ID: 9052504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis.
    Jurkowska G; Grondin G; Morisset J
    Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic exocrine function during acute exacerbation in WBN/Kob rats with spontaneous chronic pancreatitis.
    Sugiyama M; Kobori O; Atomi Y; Wada N; Kuroda A; Muto T
    Int J Pancreatol; 1996 Dec; 20(3):191-6. PubMed ID: 9013280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exocrine pancreatic function in rats after acute pancreatitis.
    Czakó L; Yamamoto M; Otsuki M
    Pancreas; 1997 Jul; 15(1):83-90. PubMed ID: 9211497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the microtubule-disrupting drug colchicine on rat cerulein-induced pancreatitis in comparison with the microtubule stabilizer taxol.
    Ueda T; Takeyama Y; Adachi M; Toyokawa A; Kishida S; Yamamoto M; Saitoh Y
    Pancreas; 1995 Oct; 11(3):294-302. PubMed ID: 8577685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats.
    Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
    Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats.
    De Dios I; Manso MA
    Pancreas; 1994 Mar; 9(2):212-8. PubMed ID: 7514791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids effects on exocrine pancreatic secretion in caerulein-induced acute pancreatitis in the rat.
    de Dios I; San Romàn JI; Manso M; Calvo JJ; López MA
    Arch Int Physiol Biochim; 1990 Dec; 98(6):361-9. PubMed ID: 1705775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide YY ameliorates cerulein-induced pancreatic injury in the rat.
    Tito JM; Rudnicki M; Jones DH; Alpern HD; Gold MS
    Am J Surg; 1993 Jun; 165(6):690-6. PubMed ID: 7685154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis.
    Hirano T
    Scand J Gastroenterol; 1997 Jan; 32(1):84-8. PubMed ID: 9018772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
    Nakano S; Tachibana I; Otsuki M
    Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Effect of Obestatin in the Course of Cerulein-Induced Acute Pancreatitis.
    Bukowczan J; Cieszkowski J; Warzecha Z; Ceranowicz P; Kusnierz-Cabala B; Tomaszewska R; Dembinski A
    Pancreas; 2016; 45(5):700-6. PubMed ID: 26474436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.